A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution

Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
10/2006
10/25/2006	CN1281230C Medicine composition for curing burn, scald and mucocutaneous ulcer
10/25/2006	CN1281228C Medicine for hyperplasia of mammary glands and its preparation
10/25/2006	CN1281227C Bunao Yishen Runchang Capsule for replenishing brain and kidney and moistening intestines
10/25/2006	CN1281222C Drug composition for preventing and treating prospermia and/or sexual excitation hypersensitivity
10/25/2006	CN1281220C Lactic acid bacteria for treatment and/or prophylaxis of glardiasis
10/25/2006	CN1281219C Medicine for treating piles and its preparation method
10/25/2006	CN1281218C Preparation method of clam meat extract
10/25/2006	CN1281161C Anti-fatigue health-care food and production thereof
10/25/2006	CN1281158C Extraction of water soluble organic calcium from egg shell of birds and preparation of two-calcium nutrient intensifying liguor
10/24/2006	US7126039 Animal tissue with carbohydrate antigens compatible for human transplantation
10/24/2006	US7125964 Using magnetic beads conjugated with major histocompatability complex peptides to purify and expand in vitro tumor- and virus-specific killer lymphocytes for use in cell therapy, tissue targeted therapy and engineering
10/24/2006	US7125958 membrane proteins acting as binding ligands to mucopolysaccharide receptors for antigens present on the surfaces of palsmodium infected erythrocytes; drugs; antibodies
10/24/2006	US7125897 Slowing or arresting progression of plaque in blood systems treatment with statins and oxidation
10/24/2006	US7125858 Hyaluronic acid in the treatment of cancer
10/24/2006	US7125841 Mutants and heparin for blood disorders
10/24/2006	US7125713 Human mullerian duct-derived epithelial cells and methods of isolation and uses thereof
10/24/2006	US7125708 Composition comprising a Lactobacillus pentosus strain and uses thereof
10/24/2006	US7125706 Method for the production and purification of adenoviral vectors
10/24/2006	US7125659 Method and screening candidate compounds for drug against tumor
10/24/2006	US7125569 Removal of plasmin(ogen) from protein solutions
10/19/2006	WO2006110731A2 Stable dairy components effective for fat loss
10/19/2006	WO2006110689A2 Method of increasing the function of an aav vector
10/19/2006	WO2006110491A2 Complementary compositions to reduce blood glucose levels and treat diabetes
10/19/2006	WO2006110406A2 Compositions comprising probiotic and sweetener components
10/19/2006	WO2006110088A1 Selection and use of lactic acid bacteria for reducing inflammation in mammals
10/19/2006	WO2006110054A1 Swine population having low levels of porcine endogenous retrovirus and uses thereof
10/19/2006	WO2006109344A2 Composition to be used for the treatment of parodontal pathologies
10/19/2006	WO2006109300A1 Pre-transplantation treatment of donor cells to control graft versus host disease (gvhd) in transplant recipients
10/19/2006	WO2006109286A1 Filamentous hemagglutinin for the prevention of the development of neutralising antibodies to a biologic agent
10/19/2006	WO2006109285A1 Methods and compounds for the treatment of autoimmune diseases and chronic inflammatory conditions
10/19/2006	WO2006108824A1 Infant formula with probiotics
10/19/2006	WO2006108284A1 Methods for the derivation of germ cells from skin stem cells
10/19/2006	WO2006108229A1 Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
10/19/2006	WO2006078782A3 Compositions containing agm cells and methods of use thereof
10/19/2006	WO2006074094A3 Method for producing probiotically derived compounds
10/19/2006	WO2006068932A3 Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders
10/19/2006	WO2006065139A3 Deacylation of lps in gram negative bacteria
10/19/2006	WO2006052135A3 Satiety enhancing compositions
10/19/2006	WO2006046871A3 Peri-operative composition comprising lactobacillus rhamnosus
10/19/2006	WO2005104790A3 Treatment of muscular dystrophy with mobilized peripheral blood pluripotent cells
10/19/2006	US20060235082 Long-chain, straight-chain 2-amino-3-hydroxyalkanes
10/19/2006	US20060234924 A kit for screening a compound or its salt that promotes or inhibits the activity of the proteins; drug screening for hyperlipemia, arteriosclerosis, genital, digestive, respiratory diseases, renal, pancreatic, central nerve, respiratory, inflammatory, rheumatoid diseases and diabetic neurosis
10/19/2006	US20060234376 Repair and regeneration of ocular tissue using postpartum-derived cells
10/19/2006	US20060234373 Treatment for diabetes
10/19/2006	US20060234344 Protein kinases
10/19/2006	US20060234271 Methods for the diagnosis and treatment of metastatic prostate tumors
10/19/2006	US20060233884 Sexual hygienic composition
10/19/2006	US20060233845 Micro/nanoparticle obtained from lipid-containing marine organisms for use in pharmaceutics and cosmetics
10/19/2006	US20060233833 Novel uses of parapoxvirus preparations
10/19/2006	US20060233806 Removal promoters and inhibitor for apoptosis cells in vivo
10/19/2006	US20060233795 Methods for selectively modulating a Th2-type response within a population of activated CD4+ T cells
10/19/2006	US20060233782 Polypeptide; a deletion mutant of chondroitinase ABC Type I truncated by a deletion; retains its proteoglycan degrading activity; neurological functional recovery after central nervous system injury or disease
10/19/2006	US20060233774 Composition for the improvement of liver function, the reduction of serum ethanol level and antioxidant activity enhancement
10/19/2006	US20060233769 Established cell line of microglia
10/19/2006	US20060233768 Elective collection and banking of autologous peripheral blood stem cells
10/19/2006	US20060233767 fabricating urinary bladder tissue by culturing a collagen based acellular tissue membrane obtained from of urinary bladder, urinary bladder submucosa, aorta, urethra, small intestinal submucosa or dermal matrix together with smooth muscle cells and interstitial fibroblastic cells from a urinary bladder
10/19/2006	US20060233766 Treatment of Parkinson's disease and related disorders using postpartum derived cells
10/19/2006	US20060233765 Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
10/19/2006	US20060233764 Skin regeneration system
10/19/2006	US20060233763 Cartilaginous cell culture medium and the use thereof
10/19/2006	US20060233753 Administering an adenovirus defective in its VAI and VAII virus-associated RNAs
10/19/2006	US20060233751 Population of natural cells, 50% are autoantigen-specific regulatory T cells
10/19/2006	US20060233745 Enclosures housing cell-coated supports for treating tumors
10/19/2006	US20060233737 Composition comprising an extract of aphanizomenon flos-aquae, use thereof and preparation of same
10/19/2006	DE102005017551A1 Recovery, preparation and storage of stem cells from umbilical cord blood, useful e.g. for autologous treatment of anemias, cancer, AIDS and thalassemia
10/19/2006	CA2604835A1 Compositions comprising probiotic and sweetener components
10/19/2006	CA2604493A1 Isolation of adult multipotential cells by tissue non-specific alkaline phosphatase
10/19/2006	CA2604344A1 Stable dairy components effective for fat loss
10/19/2006	CA2604338A1 Infant formula with probiotics
10/19/2006	CA2603580A1 Swine population having low levels of porcine endogenous retrovirus and uses thereof
10/18/2006	EP1712563A1 Method of isolating monocytes
10/18/2006	EP1712243A1 Gene therapy for tumor using minus-strand rna viral vectors encoding immunostimulatory cytokines
10/18/2006	EP1712140A1 Food product for prevention of fragility syndrome with elderly people
10/18/2006	EP1711635A1 Genes associated with canine osteoarthritis and related methods and compositions
10/18/2006	EP1711597A2 Human hepatic progenitor cells and methods of use thereof
10/18/2006	EP1711595A2 Use of polysulphated alginate in cellular matrices
10/18/2006	EP1711204A1 Monoparaimmunity inducers based on attenuated rabbit myxoma viruses
10/18/2006	EP1711193A2 IMPROVING PROFILES OF LIPID PROTEINS AND INHIBITING HMG-CoA REDUCTASE
10/18/2006	EP1711176A1 Immunomodulatory alkaloids
10/18/2006	EP1711174A1 Adjuvant compositions
10/18/2006	EP1389236B1 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof
10/18/2006	EP1358332B1 A serpin in bifidobacteria
10/18/2006	EP1326654B1 Methods and compositions for tissue regeneration
10/18/2006	EP1325749B1 Use of a bone metabolism improving agent
10/18/2006	EP1272203B1 Treatment of neurodegenerative gastrointestinal disorders by implanting neural stem cells and/or progeny thereof into gastrointestinal organs
10/18/2006	EP1194554B1 Delivery of trefoil peptides
10/18/2006	EP1183383B1 Siv-based packaging-deficient vectors
10/18/2006	EP1165778B1 Uses of casb618 polynucleotides and polypeptides
10/18/2006	EP1150577B1 Improved microbial preparations
10/18/2006	EP1079868B1 Apparatus for inactivating contaminants in biological fluid
10/18/2006	EP1003533B1 Use of herpes vectors for tumor therapy
10/18/2006	EP0939828B1 Herpesvirus saimiri as viral vector
10/18/2006	CN1849395A HLA-a24 binding cancer antigen peptide derived from ribin
10/18/2006	CN1849388A Lactic acid bacteria having mucosal immunopotentiation effect
10/18/2006	CN1849313A 抗生素化合物 Antibiotic compounds
10/18/2006	CN1849152A Device and method for applying active substances to the surface of a wound
10/18/2006	CN1849129A Method for the production of an agent from larvae in flies for treating wounds and agent produced according to said method
10/18/2006	CN1849076A Milk fractions and milk preparations for treating and/or preventing COX-2 mediated diseases
10/18/2006	CN1847259A Preparation of a therapeutic composition
10/18/2006	CN1846784A Amphioxus PE glucoprotein and its production process

1 ... 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 ... 1259